Fredrik Erlandsson

Company: Vifor Pharma

Job title: Vice President, Head of Global Clinical Development

Seminars:

Panel Discussion: Streamlining or Impeding Clinical Success? Defining the Balance Between Precision Medicine & Patient Exclusion 12:00 pm

How far should we be selecting patients that are fast progressors to streamline understanding of efficacy? Segmenting patients in rare kidney diseases: how homogeneous does the patient population need to be in a small patient population? Considering impact of precision medicine on commercial viability of drugs and ethical implications of excluding patients from trialsRead more

day: Day Two